Erez Hadar - Utron Chief Mang
| UTRN Stock | 364.90 2.10 0.57% |
Insider
Erez Hadar is Chief Mang of Utron
| Phone | 972 3 977 8899 |
| Web | https://www.utron-parking.com |
Utron Management Efficiency
The company has return on total asset (ROA) of 0.0159 % which means that it generated a profit of $0.0159 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0318) %, meaning that it generated substantial loss on money invested by shareholders. Utron's management efficiency ratios could be used to measure how well Utron manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Meni Baruch | Bezeq Israeli Telecommunication | 48 | |
| Mickey Atir | Photomyne | N/A | |
| Liat Nissan | Clal Biotechnology Industries | N/A | |
| Tomer Raved | B Communications | 38 | |
| Annat Katz | Photomyne | N/A | |
| Natalie Verter | Photomyne | 43 | |
| Eyal CPA | Opal Balance | 37 | |
| Ilan Chaikin | B Communications | 69 | |
| Yaniv Salomon | B Communications | N/A | |
| Eiran LevTov | Automatic Bank Services | N/A | |
| Meir Alberg | Automatic Bank Services | 48 | |
| Zvika Abramovich | Bezeq Israeli Telecommunication | N/A | |
| Shmulik Gottlieb | Automatic Bank Services | 68 | |
| Ofer CPA | Automatic Bank Services | 64 | |
| Tobi Fischbein | Bezeq Israeli Telecommunication | 50 | |
| Roman Rosental | Mivne Real Estate | N/A | |
| Omer Shoor | Photomyne | 45 | |
| Arnon MD | Clal Biotechnology Industries | 54 | |
| Maxim Nijonzin | Automatic Bank Services | 59 | |
| Tal Katz | Photomyne | N/A | |
| Iris Sadeh | Clal Biotechnology Industries | N/A | |
Management Performance
| Return On Equity | -0.0318 | |||
| Return On Asset | 0.0159 |
Utron Leadership Team
Elected by the shareholders, the Utron's board of directors comprises two types of representatives: Utron inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Utron. The board's role is to monitor Utron's management team and ensure that shareholders' interests are well served. Utron's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Utron's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Haim Shani, CEO, Director | ||
| Christopher Lawson, VP Operations | ||
| Reuven Perel, Chief Officer | ||
| Yair Goldberg, Ex Marketing | ||
| Levia Maoz, Chief Officer | ||
| Erez Hadar, Chief Mang |
Utron Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Utron a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0318 | |||
| Return On Asset | 0.0159 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 126.57 M | |||
| Shares Outstanding | 20.57 M | |||
| Shares Owned By Insiders | 19.42 % | |||
| Shares Owned By Institutions | 51.19 % | |||
| Price To Sales | 1.74 X | |||
| Revenue | 110.28 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Utron Stock
Utron financial ratios help investors to determine whether Utron Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Utron with respect to the benefits of owning Utron security.